Benzinga | Jun 30, 2021 06:00AM EDT

Adamis Pharma Received FDA Approval on Labeling for Symjepi 0.3MG/0.3ML (0.3MG/0.3ML); 0.15MG/0.3ML (0.15MG/0.3ML)

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207534